Lilly to sell cheaper version of top-selling insulin Humalog
Eli Lilly is offering a half-price version of its top-selling insulin Humalog as drugmakers face growing pressure to control prices.
Monday, March 4, 2019
Lilly to sell cheaper version of top-selling insulin Humalog
Lilly to sell cheaper version of top-selling insulin Humalog
Eli Lilly is offering a half-price version of its top-selling insulin Humalog as drugmakers face growing pressure to control prices.
Related Posts:
Activist investor Land & Buildings resumes criticism of Hudson's Bay- In Hitting China on Trade, Trump Is Seen Neglecting U.S. Emerging Industries
- How a for-profit company aims to help refugees by giving them jobs
- U.S. top court lets states force online retailers to collect sales tax
- Wall Street falls as Amazon weighs, trade worries linger
0 comments:
Post a Comment